DECISION DIAGNOSTICS DECN news, videos and press releases
For more news please use our advanced search feature.
DECISION DIAGNOSTICS DECN - More news...
DECISION DIAGNOSTICS DECN - More news...
- ROSEN, A LEADING LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Decision Diagnostics Corp. – DECN
- DECN to Announce Various Testing Results This Week for Its COVID-19 GenViro! Swift Kit
- DECN Comments on Recent Legal Filings by Federal Agencies
- DECN EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Decision Diagnostics Corp. – DECN
- DECN Provides Testing Update for US, Korea and XPRIZE With Plans for Walk-in Donor Study for at-Home GenViro! Saliva Swift :10 Test Kit
- DECN Secures Exclusive Distributor Agreement With a German Based Company for the Distribution of Genviro! Covid-19 :10 Saliva Testing Kits and Meters in 18 EU Countries, Norway and the UK
- DECN Announces Significant Agreement With Russian Federation Partner for Genviro! and Genviro! Pro COVID-19 Testing Kits as Well as Its Venerable GenUltimate! Blood Glucose Products
- DECN XPRIZE Testing Data for Rapid COVID-19 Testing Technology Yields Near Textbook Results
- DECN GenViro! Trial Using Human Saliva Donors for Its Swift Test Kits Proceeds Directly to FDA Level Testing As COVID-19 Product Testing Enters “Home Stretch”
- DECN Continues to Add GenViro! Dealers With an Agreement Covering Puerto Rico, the Dominican Republic, the US Virgin Islands and Geographies Across the Caribbean and Central America
- DECN Announces Additional Distribution Agreement With a Distributor and Dealers in Nigeria, Ivory Coast and Lebanon
- DECN Announces Commencement of US-Based Donor Study for FDA EUA Guidance Testing for Their 10.5 Second Genviro! Saliva Swift COVID-19 Test Kits
- DECN Provides Progress Update on Major Events for Its GenViro! Saliva Swift Kits for the Detection of COVID-19
- DECN Enters into a New 6 Month $300,000 Promissory Note with Major Current Investor to Help Fund the Recent International Launch if its GenViro! Swift Kits
- DECN Receives Significant Initial Order for International GenViro! Saliva Swift Kits for the Detection of COVID-19
- DECN Signs Agreement With US-Based Laboratory as Testing Partner for Genviro! Saliva Swift Kit Testing for Additional FDA, EU CE Mark and Russian Federation Submissions
- DECN Announces Completion of Critical Instructional Videos for its GenViro! Saliva Swift Kit for USA and International Professional Use
- DECN Announces Finalizing of International Genviro! COVID-19 Saliva Swift Kits for Global Market and Establishes Introductory Sales Pricing
- DECN Enters into an Additional 6 Month $300,000 Promissory Note With Major Current Investor to Further Assist Launch of Genviro Swift Kits for the Detection of the Covid-19 Virus
- DECN to Launch Its International Version GenViro! Saliva Swift :10.5 Second Covid-19 Kits on September 26, Will Then Accept Orders from Its Asian Distributor
- DECN Provides Update on Accomplishments and Pathway to Securing FDA EUA Approval for its COVID-19 "Transmission Indicating Testing" Methodology
- DECN CEO Releases Open Letter on FDA At-Home COVID-19 Rapid Testing Guidelines Saying It's the Speed to Results Reporting and Certain Added Regulations That Need to Be Addressed
- DECN Publicly Disavows Covid-19 Swift Kit Video as Produced by Outside Unauthorized Party
- DECN Issues Support for Recently Announced FDA COVID-19 At-Home Testing Template as the Company's Submission for Its Genviro! Swift COVID-19 At-Home Test Kit Anticipated Many of the New FDA Requisites
- DECN Readies its GenViro! Covid-19 Swift Kits for Latest FDA Mandated Testing of both Saliva and Blood Protocols as it Enters Final Selection Process for a U.S. Based Testing Partner
- DECN Says its Newest GenViro! COVID-19 Swift Kit Saliva Testing Option Can Play an Extensive Role in the Re-Opening of Schools as Company Awaits FDA Authorization
- DECN to add GenViro! Saliva Covid-19 Swift Kit :10.5 for Professional and Home Use Testing, Providing an Alternative Modality to its Finger Stick Methodology
- DECN Announces Distribution Agreement Covering GenViro! Covid-19:10.5 Swift Kits and Its GenUltimate and TGB Products in India, Malaysia, Sri Lanka, Singapore, Indonesia, Thailand, Vietnam, Nepal, Bangladesh and Australia
- DECN CEO Offers Open Letter on COVID-19 Testing Highlighting Needed Support for Innovation in Testing
- DECN Files Provisional Patent For GenViro! Professional COVID-19 :15 Swift Kit, Adds Enhanced Technology To Allow For Even Swifter Results
